Characterization of the mammalian mRNA-3'-end processing complex

哺乳动物 mRNA-3 末端加工复合物的表征

基本信息

  • 批准号:
    8963877
  • 负责人:
  • 金额:
    $ 30.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-15 至 2019-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Project Summary: The long-term goal of this proposal is to understand, in detail, the mechanisms of mammalian mRNA 3' processing and its regulation. mRNA 3'-end formation, typically involving an endonucleolytic cleavage followed by polyadenylation, is an essential step of eukaryotic gene expression and it significantly impacts many aspects of RNA metabolism, including mRNA stability and translation. In addition, the majority of eukaryotic genes produce multiple mRNA isoforms with distinct 3' ends through alternative polyadenylation (APA). Recent studies have revealed that APA is highly regulated in development and plays an important role in post-transcriptional gene regulation. Aberrant APA patterns have been associated with a wide range of diseases, from cancer to neuromuscular disorders. As such, a central question in the mRNA 3' processing field has been how polyadenylation sites (PAS) are recognized and how PAS selection can be regulated. The majority of mammalian PAS contain an AAUAAA hexamer and a U/UG-rich downstream element (DSE). According to the current model in the field, these key cis-elements are specifically recognized by CPSF160 of the CPSF complex and CstF64 of the CstF complex respectively. However, our published and preliminary data have challenged this model in several key aspects: 1) we have recently shown that the CPSF subunits CPSF30 and Wdr33, but not CPSF160 as was generally believed, directly bind to AAUAAA; 2) we have provided evidence that maintenance of the CPSF-RNA interaction specificity requires a novel proofreading factor(s) (see preliminary data); 3) we have demonstrated that the general 3' processing factor CstF64 in fact only binds to a subset of mammalian PAS, and we provided evidence that recognition of PAS with different sequence features requires distinct RNA-binding protein(s) (see preliminary data). These observations have not only significantly changed the current model for PAS recognition, but also revealed much greater complexity in mRNA 3' processing than previously appreciated. Here we propose to better define the molecular mechanisms of mammalian PAS recognition through an in-depth characterization of the key protein-RNA interactions involved. Accomplishing the proposed research will provide seminal insights into the fundamental mechanisms of mammalian mRNA 3' processing and its regulation. As aberrant PAS selection has been associated with a broad spectrum of human diseases, a better understanding of the mechanisms for PAS recognition may provide the foundation for the development of new therapeutics for these diseases.
 描述(由申请人提供): 项目摘要:这项建议的长期目标是详细了解哺乳动物信使核糖核酸3‘加工及其调控的机制。MRNA3‘端的形成是真核基因表达的重要步骤,它对RNA代谢的许多方面都有重要影响,包括mRNA的稳定性和翻译。此外,大多数真核基因通过交替多聚腺苷酸化(APA)产生具有不同3‘端的多种mRNA异构体。最近的研究表明,APA在发育过程中受到高度调控,并在转录后基因调控中发挥重要作用。APA模式的异常与多种疾病有关,从癌症到神经肌肉疾病。因此,mRNA3‘加工领域的一个中心问题是如何识别多聚腺苷酸化位点(PA)以及如何调控PAS选择。大多数哺乳动物PA含有AAUAAA六聚体和富含U/UG的下游元件(DSE)。根据目前的模型,这些关键的顺式元件分别被CPSF复合体的CPSF160和CstF复合体的CstF64特异性识别。然而,我们已发表的和初步的数据在几个关键方面对该模型提出了质疑:1)我们最近发现CPSF亚单位CPSF30和Wdr33,而不是通常认为的CPSF160直接与AAUAAA结合;2)我们提供的证据表明,保持CPSF-RNA的相互作用专一性需要一个新的校对因子(S)(见初步数据);3)我们已经证明一般的3‘处理因子CstF64实际上只与哺乳动物PA的一个亚组结合,并且我们提供的证据表明识别具有不同序列特征的PA需要不同的RNA结合蛋白(见初步数据)(见初步数据)。这些观察结果不仅显著改变了目前PAS识别的模型,而且揭示了mRNA3‘处理的复杂性比以前所认识的要大得多。在这里,我们建议通过深入描述所涉及的关键蛋白质-RNA相互作用来更好地定义哺乳动物PAS识别的分子机制。这项研究的完成将为哺乳动物mRNA3‘处理及其调控的基本机制提供开创性的见解。由于PAS的异常选择与人类多种疾病有关,对PAS识别机制的更好理解可能为这些疾病的新疗法的开发提供基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yongsheng Shi其他文献

Yongsheng Shi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yongsheng Shi', 18)}}的其他基金

Mechanisms and regulation of mRNA 3' processing
mRNA 3 加工的机制和调控
  • 批准号:
    10623768
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms and regulation of mRNA 3' processing
mRNA 3 加工的机制和调控
  • 批准号:
    10824010
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Molecular basis of the anti-cancer and anti-inflammation activities of JTE607
JTE607抗癌和抗炎活性的分子基础
  • 批准号:
    10354133
  • 财政年份:
    2021
  • 资助金额:
    $ 30.2万
  • 项目类别:
Molecular basis of the anti-cancer and anti-inflammation activities of JTE607
JTE607抗癌和抗炎活性的分子基础
  • 批准号:
    10495260
  • 财政年份:
    2021
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterization of the mammalian mRNA 3???-end processing complex
哺乳动物 mRNA 3???-末端加工复合物的表征
  • 批准号:
    7769121
  • 财政年份:
    2010
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterization of the mammalian mRNA 3???-end processing complex
哺乳动物 mRNA 3???-末端加工复合物的表征
  • 批准号:
    8436286
  • 财政年份:
    2010
  • 资助金额:
    $ 30.2万
  • 项目类别:
PROTEOMIC ANALYSIS OF THE EUKARYOTIC PRE-MRNA 3' PROCESSING COMPLEX
真核前 mRNA 3 加工复合物的蛋白质组学分析
  • 批准号:
    8171344
  • 财政年份:
    2010
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterization of the mammalian mRNA 3'-end processing complex
哺乳动物 mRNA 3 端加工复合物的表征
  • 批准号:
    9901538
  • 财政年份:
    2010
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterization of the mammalian mRNA 3???-end processing complex
哺乳动物 mRNA 3???-末端加工复合物的表征
  • 批准号:
    8233402
  • 财政年份:
    2010
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterization of the mammalian mRNA 3'-end processing complex
哺乳动物 mRNA 3 端加工复合物的表征
  • 批准号:
    10580430
  • 财政年份:
    2010
  • 资助金额:
    $ 30.2万
  • 项目类别:

相似海外基金

EAGER: Dating Arctic Lake Sediments with Beryllium-10 Markers of Solar Proton Events
EAGER:利用太阳质子事件的铍 10 标记测定北极湖沉积物的年代
  • 批准号:
    2404514
  • 财政年份:
    2024
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Standard Grant
Predictive Models of Beryllium Sensitization and Chronic Beryllium Disease
铍致敏和慢性铍病的预测模型
  • 批准号:
    10736862
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease
使用多组学来定义肉芽肿性炎症和慢性铍病的调节因素和驱动因素
  • 批准号:
    10569103
  • 财政年份:
    2022
  • 资助金额:
    $ 30.2万
  • 项目类别:
Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease
使用多组学来定义肉芽肿性炎症和慢性铍病的调节因素和驱动因素
  • 批准号:
    10339740
  • 财政年份:
    2022
  • 资助金额:
    $ 30.2万
  • 项目类别:
Intermetallic and Extraordinary Bonds of Beryllium and the Alkaline Earth Metals
铍和碱土金属的金属间键和非常键
  • 批准号:
    2055579
  • 财政年份:
    2021
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Continuing Grant
Combined Effects of Light Gas and Damage Accumulation in Beryllium
铍中轻气体和损伤累积的综合效应
  • 批准号:
    EP/T027215/1
  • 财政年份:
    2020
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Research Grant
Combined Effects of Light Gas and Damage Accumulation in Beryllium
铍中轻气体和损伤累积的综合效应
  • 批准号:
    EP/T027193/1
  • 财政年份:
    2020
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Research Grant
CAREER: Retention and Mobility of Beryllium in Soils and Sedimentary Environments
职业:铍在土壤和沉积环境中的保留和移动性
  • 批准号:
    2103501
  • 财政年份:
    2020
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Standard Grant
Intermetallic and Extraordinary Bonds of Beryllium and the Alkaline Earth Metals
铍和碱土金属的金属间键和非常键
  • 批准号:
    1900555
  • 财政年份:
    2019
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Continuing Grant
CAREER:Laser Cooling and Trapping of Beryllium: Frozen Plasmas and Precision Measurements
职业:铍的激光冷却和捕获:冷冻等离子体和精密测量
  • 批准号:
    1848154
  • 财政年份:
    2019
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了